Singaporean startup Mesh Bio has raised $3.5 million in a Series A funding round led by East Ventures. The round was also participated by Elev8, Seed Capitals, and its other shareholders.
WHAT IT'S FOR
In a statement, the company said it will use its fresh funds to scale the deployment of its solutions, particularly its flagship digital twin offering, across Hong Kong and Southeast Asia.
The...
Mesh Bio secures funding for refining digital twin engine
Singaporean startup Mesh Bio has received undisclosed funding from East Ventures to assist with its regional expansion.
The company is currently working on a digital twin solution for managing rising cases of chronic diseases, particularly in Southeast Asia, where 62% of all deaths in the region are due to non-communicable conditions. Mesh...
Singaporean health tech startup Mesh Bio and UK-based drug discovery firm MultiOmic Health have started collaborating to build a huge multi-omics dataset that will provide insights into metabolic syndrome-related conditions among Asians.
WHAT IT'S ABOUT
According to a press statement, Mesh Bio will tap on its network of healthcare providers to recruit participants for their study, specifically...
